GMO US Value ETF
GMOV
7 hedge funds and large institutions have $4.86M invested in GMO US Value ETF in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
9.38% more ownership
Funds ownership: 0% → 9.38% (+9.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cerity Partners
New York
|
+$2.47M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$757K |
| 3 |
LCWP
Legacy Capital Wealth Partners
Little Rock,
Arkansas
|
+$507K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$474K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$435K |
Top Sellers
GMOV Hedge Fund Activity: Q4 2024 in Review
7 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in GMO US Value ETF (GMOV) for Q4 2024, worth a combined $4.86M.
Buyers outnumbered sellers: 7 funds opened new GMOV positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Cerity Partners, opening a new position worth an estimated $2.47M.
- 7 institutional investors held GMO US Value ETF (GMOV) as of Q4 2024, up from 0 in Q3 2024.
- Funds reported $4.86M of GMO US Value ETF stock for Q4 2024.
- 7 funds opened new GMO US Value ETF positions in Q4 2024 and 0 closed out, a net change of +7 holders.
- The largest GMO US Value ETF buyer in Q4 2024 was Cerity Partners, an estimated $2.47M added.
Based on aggregated 13F filings for Q4 2024.